hair loss after tirzepatide and Loss: Causes, Clinical Evidence and What Really Helps with Mounjaro and Zepbound Do Ozempic, Wegovy, Mounjaro &

No Hype, No Claims, Just Proven Skincare Ingredient Innovation

ADVANTAGES & DISADVANTAGES OF TREATMENT OPTIONS CVD: Cardiovascular Death Management of Type 2 Diabetes American Diabetes Assn 2020 Update Based upon recent research findings, the American Diabetes Asson & Europiean Asson for the Study of Diabetes recently updated their consensus treatment recommendations (Buse et al, 2019) for the following subsets of patients with diabetes: High risk diabetic patients GLP-1 agonists & SGLT2 inhibitors to reduce CV & renal risk in high risk patients, without regard to patient HbA1c levels (baseline or target) High risk for atherosclerotic CV disease GLP-1 agonists GLP-1 agonists produce the greatest benefit against CV events Systolic heart failure (HFrEF) & chronic kidney disease (CKD) SGLT2 inhibitors SGLT2 inhibitors have the greatest benefit to prevent progression of CKD, reduce hospitalization for HF, and reduce CV events & CV death Patients with foot ulcers SGLT2 inhibitors a recommended treatment, after consideration of risk vs benefits 2021 ADA Treatment Guidelines Figure 10

Hafez, H

#psychiatry #pmhnp #weightloss To view or add a comment, sign in Momentum in psychedelic therapeutics continues

When infused back into the bloodstream, lifileucel finds cancer cells, recognizes them as abnormal and eliminates them